Medicinal Phenotypes

Medicinal phenotypes refer to cannabis plant expressions selected and preserved by breeders for specific biochemical profiles—typically elevated cannabinoid diversity, terpene complexity, or balanced ratios of compounds like CBD, CBG, and minor cannabinoids. These phenotypes emerge from genetic lineages historically associated with therapeutic research or traditional cultivation practices, though modern breeding has formalized selection criteria. The category encompasses diverse genetic backgrounds, from landrace-derived strains to contemporary crosses engineered for consistent cannabinoid expression. Medicinal phenotypes are not defined by effects or health claims, but rather by measurable chemical composition and breeding stability. Preservation and documentation of these phenotypes remain important for genetic libraries and breeding programs exploring cannabinoid chemistry.

Breeders working with medicinal phenotypes prioritize consistent cannabinoid ratios, secondary metabolite production, and heritability across generations. These selections serve as parent stock for crosses targeting specific chemical profiles rather than single-cannabinoid dominance.